NeuBase
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
350 Technology Dr Ste 421, Pittsburgh, P...Phone Number
(412) 763-3350Website
www.neubasetherapeutics.comRevenue
$7.8 MillionStock Symbol
NBSEIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About NeuBase
NeuBase is accelerating the genetic revolution using a new class of synthetic medicines which have been shown to be able to increase, decrease and change gene function, as appropriate, to resolve causal genetic defects in living systems. Established in 2009, NeuBase is headquartered in Pennsylvania, United States.Explore more
NeuBase Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuBase your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when NeuBase launches new products
Click to see if NeuBase had a recent Job posting/layoffs
Earning: See what the market has to say on NeuBase recently announced quarterly report
NeuBase, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NeuBase
Funding: Get notified immidiatlly once NeuBase has new funding data
Check if NeuBase has recently received funding, and reach out quickly before it becomes old news!
Check out if NeuBase is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at NeuBase
Find 2 more new buyers
Compare Similar Companies to NeuBase
Compare insights from companies similar to NeuBase, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
NeuBase is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeuBase is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeuBase.
NeuBase financials insights
Gather financial insights about NeuBase, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$46M
NeuBase Tech Stack
A closer look at the technologies used by NeuBase
Most Recent Scoops
Promotion
Executive Move
New Hire
Executive Move
NeuBase has announced that Todd Branning has joined the organization as Chief Financial Officer. Previously, Branning served as Chief Financial Officer for Phathom Pharmaceuticals.
Executive Move
Board of Directors
Left Company
Executive Move
Executive Move
Executive Moves
NeuBase News & Media
NeuBase Therapeutics Strikes Definitive Warrant Agreement - TipRanks.com
NeuBase Therapeutics Inc (NBSE) has released an update to notify the public and investors about an entry into a material definitive agreement. NeuBase Therapeutics,...Symetryx exits stake in NeuBase Therapeutics, shares fall (NASDAQ:NBSE) | Seeking Alpha
NeuBase Therapeutics (NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.Symetryx sold 203,337 shares in the price range...SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
URGES BOARD TO CONSIDER A $1 DIVIDEND TORONTO, Sept. 6, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announced that it has acquired 20% of the issued and outstanding common stock in Neubase Therapeutics Inc. (NASDAQ: NBSE) ("Neubase"). Symetryx is now urging the Board to...NeuBase Announces Closing of $5 Million Concurrent - GlobeNewswire
PITTSBURGH, June 30, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuBase
Sign Up For FreeTo access detailed company insights
NeuBase is accelerating the genetic revolution using a new class of synthetic medicines which have been shown to be able to increase, decrease and change gene function, as appropriate, to resolve causal genetic defects in living systems. Established in 2009, NeuBase is headquartered in Pennsylvania, United States.... Read More
